Over 26,000 people living in Scotland today have been diagnosed with bowel cancer – making it the third most common cancer in the country. Bowel cancer is also the nation’s second biggest cancer killer, however it shouldn’t be because it is treatable and curable especially if diagnosed early. That’s why we’ve teamed up with Bowel Cancer UK as our exclusive fundraiser for our Dinner and Annual Awards on Thursday 28 February 2019.
Bowel Cancer UK is the UK’s leading bowel cancer charity. They support and fund targeted research, provide expert information and support to patients and their families, educate the public and professionals about the disease and campaign for early diagnosis and access to best treatment and care.
Money raised from our award ceremony will go towards their ambitious ‘Improving Surgery, Saving Lives’ fundraising appeal. They need our help to raise £430,000 for surgical bowel cancer research to establish Scotland’s first Colorectal Cancer Surgical Research Chair, in partnership with the Royal College of Surgeons of Edinburgh.
The research chair will drive forward the surgical clinical trial agenda for bowel cancer, growing the number of surgical trials focussed on bowel cancer and increasing patient access to them in Scotland.
Bowel Cancer UK will be joining us at our Dinner and Annual Awards, where you will have the opportunity to find out more about the project and donate to their appeal.
To find out more about the ‘Improving Surgery, Saving Lives’ appeal, email: email@example.com
Highlands and Islands Enterprise (HIE) is the economic and community development agency delivering the Scottish Government’s economic strategy across the north and west of Scotland, a region which covers more than half of Scotland.
With around 300 staff, HIE supports hundreds of client businesses and social enterprises; strengthens communities, particularly in fragile areas; develops key sectors, and invests in infrastructure to create a more competitive and low carbon region.
As one of our priority sectors for growth, Life Sciences are key to the economic development of our region. In particular the sub-sectors Medical Technologies and Diagnostics, Digital Health and Marine Biotechnology play an important role and are well represented across the business base and academic expertise
Skills Development Scotland is the national skills body supporting the people and businesses of Scotland to develop and apply their skills.
With more than 1,400 colleagues working across the country in schools, careers centres and partner locations, we are passionate about skills development and its contribution to a modern, innovative and prosperous Scottish economy.
Working with our partners, we strive to ensure employers have the right skills at the right time in high performing, fair and equal workplaces, and that every individual has the skills and confidence to get a job and progress in the workplace, achieving their full potential.
Haseltine Lake is a major European Intellectual Property practice. With decades of experience in helping life sciences businesses protect their valuable innovations, Haseltine Lake can unlock the power of your IP.
Our team of highly qualified attorneys across a number of European offices in Glasgow, London, Bristol, Munich and the Netherlands, can help you get the protection you need, and make your IP budget go further. Founded in 1850, Haseltine Lake enjoys long-standing, closely integrated relationships with its clients, based on trust, transparency and flexibility.
Opportunity North East (ONE) is a privately funded and led economic development body, set up to strengthen and diversify the economy of North East Scotland and has a 10-year £62m funding commitment from The Wood Foundation.
The ONE Life Sciences sector board is leading ambitious action and investment to realise the life sciences innovation, collaboration and commercialisation opportunity in Aberdeen, focused on the city’s Foresterhill Health Campus, one of Europe’s largest integrated clinical, research and teaching sites. This includes the creation of the Bio-therapeutics Hub for Innovation, a £40m investment that aims to double the number of life sciences companies based in the region. It will provide the physical space and specialist support to accelerate the creation and growth of companies, putting the regional company cluster and wider asset base at the forefront of health innovation and commercialisation. The project has been developed by ONE Life Sciences, University of Aberdeen, Robert Gordon University, NHS Grampian and Scottish Enterprise and the ONE team is leading its delivery. It has secured £20m of capital funding via the Aberdeen City Region Deal and ONE has committed £3.6m of funding to it. The new-build facility is due to open at the end of 2020.